NCT01972724 Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy Status COMPLETED Phase PHASE4
NCT01967264 Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults Status COMPLETED Phase PHASE1
NCT01967251 Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction Status WITHDRAWN Phase PHASE2
NCT01964976 Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides Status COMPLETED Phase N/A
NCT01964963 Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01964950 Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea Status COMPLETED Phase N/A
NCT01953081 A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance Status COMPLETED Phase PHASE1/PHASE2
NCT01945242 Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones" Status COMPLETED Phase N/A
NCT01945216 Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI" Status COMPLETED Phase N/A
NCT01931566 Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset Status TERMINATED Phase PHASE3
NCT01924260 Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01922440 A Registry for Participants With Chronic Hypoparathyroidism Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01916304 Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation Status COMPLETED Phase PHASE2
NCT01911091 Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus) Status ACTIVE_NOT_RECRUITING Phase NA
NCT01909934 Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Status COMPLETED Phase PHASE4
NCT01900522 Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia Status TERMINATED Phase PHASE1
NCT01892189 Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults Status COMPLETED Phase PHASE1